ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PLX Protalix BioTherapeutics Inc

1.14
0.03 (2.70%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Protalix BioTherapeutics Inc PLX AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 2.70% 1.14 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.12 1.12 1.14 1.14 1.11
more quote information »

Recent News

Date Time Source Heading
18/5/202407:05EDGAR2Form ARS - Annual Report to Security Holders
18/5/202407:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/5/202421:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202420:59EDGAR2Form 8-K - Current report
02/1/202422:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/12/202322:56EDGAR2Form 8-K - Current report
30/11/202320:00GLOBELevicept Appoints Eliot Forster as CEO
06/11/202323:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202323:22EDGAR2Form 8-K - Current report
01/11/202307:40APSUpcoming Earnings Release Paired With Price Target Raise..
20/10/202321:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202306:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202306:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/9/202320:58EDGAR2Form 8-K - Current report
06/9/202320:50PRNUSProtalix BioTherapeutics to Present at the H.C. Wainwright..
18/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202306:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202320:59EDGAR2Form 8-K - Current report
14/7/202306:41EDGAR2Form 8-K - Current report
08/7/202306:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/6/202321:24EDGAR2Form 8-K - Current report
29/6/202306:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..